oncoamericas.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Disallow: | ||
Meta Tags
| Title | Home - Onco |
| Description | News Oncology Solutions for Professionals and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 162.214.55.113 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
oncoamericas.com Valuation
|
US$5,940,111
Last updated: 2023-05-15 03:51:00
oncoamericas.com has Semrush global rank of 1,781,836. oncoamericas.com has an estimated worth of US$ 5,940,111, based on its estimated Ads revenue. oncoamericas.com receives approximately 685,398 unique visitors each day. Its web server is located in United States, with IP address 162.214.55.113. According to SiteAdvisor, oncoamericas.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,940,111 |
| Daily Ads Revenue | US$5,484 |
| Monthly Ads Revenue | US$164,496 |
| Yearly Ads Revenue | US$1,973,945 |
| Daily Unique Visitors | 45,694 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| oncoamericas.com. | A | 14400 | IP: 162.214.55.113 |
| oncoamericas.com. | NS | 86400 | NS Record: ns2.webmdhealth.com.br. |
| oncoamericas.com. | NS | 86400 | NS Record: ns1.webmdhealth.com.br. |
| oncoamericas.com. | MX | 14400 | MX Record: 0 oncoamericas.com. |
| oncoamericas.com. | TXT | 14400 | TXT Record: google-site-verification=YWJnTVjKAMpEFP3bhv3Nawf6OddbIeKWpIbTu3fIi7A |
| oncoamericas.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:162.214.54.161 +ip4:162.214.55.113 ~all |
HtmlToTextCheckTime:2023-05-15 03:51:00
| HOME ABOUT NEWS VIDEO CONTACT Oncology Solutions for Healthcare Professionals and Companies Learn more about our digital solutions News Relatlimab and nivolumab in untreated and metastatic melanom February 18, 2022 0 In preclinical models, simultaneous inhibition of LAG-3 and PD-1 showed synergistic antitumor activity. This phase 2-3 study evaluated the combination of relatlimab (anti LAG-3) and nivolumab […] Pembrolizumab in treatment of triple-negative breast cance February 18, 2022 0 Pembrolizumab in combination with chemotherapy is already FDA-approved for the treatment of patients with triple-negative breast cancer – in the setting of early or metastatic diseases. […] Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide Carcinosarcoma of the Uterus February 18, 2022 0 This phase III study demonstrates that the combination of paclitaxel and carboplatin is non-inferior to the combination of paclitaxel and ifosfamide for the treatment of patients […] Levantinib in combination |
HTTP Headers
HTTP/1.1 302 Found Date: Fri, 24 Dec 2021 15:08:43 GMT Server: Apache Vary: Accept-Language X-Redirect-By: Polylang Location: http://www.oncoamericas.com/en/home/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 301 Moved Permanently Date: Fri, 24 Dec 2021 15:08:43 GMT Server: Apache X-Redirect-By: WordPress Location: https://www.oncoamericas.com/en/home/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Fri, 24 Dec 2021 15:08:44 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
oncoamericas.com Whois Information
Domain Name: ONCOAMERICAS.COM Registry Domain ID: 2205080390_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2021-11-25T05:34:51Z Creation Date: 2017-12-27T04:42:32Z Registry Expiry Date: 2022-12-27T04:42:32Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.WEBMDHEALTH.COM.BR Name Server: NS2.WEBMDHEALTH.COM.BR DNSSEC: unsigned >>> Last update of whois database: 2021-12-28T08:13:40Z <<< |